Who are we bridging? Description of warfarin patients receiving injectable bridging therapy
Who are we bridging? Description of warfarin patients receiving injectable…
Ler MaisWho are we bridging? Description of warfarin patients receiving injectable…
Ler MaisEfficacy and safety of antithrombin or recombinant human thrombomodulin in…
Ler MaisClinical outcomes of direct oral anticoagulants in patients with thrombosis…
Ler MaisPatients with cirrhosis have a disbalance between coagulation and fibrinolysis…
Ler MaisDiscrepancy between parallel anti-Xa and activated partial thromboplastin time is…
Ler MaisHow to deal with interference on heparin anti-Xa activity caused…
Ler MaisThe efficacy and safety of low-molecular-weight heparins for venous thromboembolism…
Ler MaisDevelopment and validation of machine learning-based prediction model for central…
Ler MaisVenous thromboembolism in children with Hodgkin lymphoma – A population-based…
Ler MaisAssociation between anticoagulant-related bleeding and mortality in patients with hematological…
Ler Mais